"In the placebo-controlled trials, overall more patients in the control group experienced SAEs than in the DPM group, 27% vs 21%, respectively. "
Another thing you can take out of the trials is that Bronchitol (despite its unpleasantness to use) reduces the incidence of Significant Adverse Events. If these stats were adjusted to actually compare those in the DPM group who did not drop out then it might be even more different. At any rate, you'd want to have a go with this stuff if you had cf.
expect another failure, page-10
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
